Aziyo Biologics Inc. (AZYO)
NASDAQ: AZYO
· Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM
Aziyo Biologics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 8.5M | 17.36M | 13.24M | 25.74M | 18.19M | 14.52M | 9.3M | 11.79M | 16.99M | 8.1M | 16.51M | 22.07M | 30.43M | 22.54M | 28.3M | 30.5M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | 2.6M | n/a | n/a | n/a | 89K | 76K | 76K | 76K | 76K | 76K | 76K |
Receivables | 3.15M | 2.86M | 2.28M | 2.93M | 3.52M | 2.88M | 6.32M | 7.33M | 6.83M | 7.16M | 6.65M | 6.01M | 6M | 5.52M | 7.75M | 8.76M |
Inventory | 5.24M | 4.29M | 3.91M | 3.63M | 3.12M | 6.5M | 9.27M | 11.05M | 10.05M | 10.19M | 9.7M | 9.86M | 9.55M | 9.83M | 10.34M | 10.22M |
Other Current Assets | 5.39M | 5.51M | 6.75M | 5.01M | 5.53M | 15.22M | 11.24M | 13.29M | 16.83M | 18.2M | 1.85M | 3.03M | 1.49M | 1.28M | 1.76M | 2.52M |
Total Current Assets | 22.28M | 30.02M | 26.17M | 37.32M | 30.35M | 39.13M | 36.13M | 43.47M | 50.7M | 43.66M | 34.68M | 41.08M | 47.43M | 39.25M | 48.22M | 51.91M |
Property-Plant & Equipment | 4.99M | 1.86M | 1.68M | 1.97M | 1.58M | 330K | 2.83M | 2.94M | 3.07M | 1.36M | 1.33M | 1.16M | 1.2M | 1.26M | 1.24M | 1.21M |
Goodwill & Intangibles | 6.58M | 7.42M | 8.27M | 9.12M | 9.97M | 12.52M | 13.37M | 14.22M | 15.07M | 15.92M | 16.77M | 17.62M | 18.47M | 19.32M | 20.17M | 21.02M |
Total Long-Term Assets | 11.57M | 9.28M | 9.96M | 11.09M | 11.55M | 15.45M | 16.2M | 17.16M | 18.14M | 17.37M | 18.17M | 18.85M | 19.74M | 20.65M | 21.48M | 22.3M |
Total Assets | 33.85M | 39.3M | 36.13M | 48.41M | 41.9M | 54.58M | 52.33M | 60.63M | 68.84M | 61.02M | 52.85M | 59.93M | 67.17M | 59.9M | 69.7M | 74.21M |
Account Payables | 6.07M | 4.52M | 4.15M | 5.07M | 3.14M | 2.96M | 3.23M | 3.5M | 2.33M | 2.62M | 1.76M | 1.72M | 1.58M | 1.69M | 1.63M | 1.97M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 14.18M | n/a | n/a | n/a | 8K | 8.63M | 5K | 110K | 251K | 392K |
Short-Term Debt | 4.16M | 2.94M | 1.71M | 491K | 3.94M | 399K | 620K | 588K | n/a | n/a | 14.51M | 14.22M | 15.57M | 10.02M | 10.41M | 14.82M |
Other Current Liabilities | 33.79M | 33.92M | 36.09M | 39.19M | 32.73M | 41.38M | 39.02M | 37.34M | 40.29M | 37.55M | 18.47M | 11.38M | 8.84M | 10.7M | 11.3M | 7.59M |
Total Current Liabilities | 37.95M | 36.85M | 37.8M | 39.68M | 39.81M | 44.74M | 42.87M | 41.42M | 42.62M | 40.17M | 34.75M | 27.32M | 26M | 22.51M | 23.6M | 24.77M |
Long-Term Debt | 28.78M | 26.82M | 28.52M | 28.89M | 25.84M | 30.75M | 31.24M | 31.17M | 25.22M | 31.45M | 18.57M | 25.28M | 10.41M | 12.05M | 13.68M | 15.53M |
Other Long-Term Liabilities | 8.97M | 12.09M | 16.08M | 20.08M | 40.59M | 8.57M | 351K | 207K | 6.04M | 86K | 899K | 771K | 17.24M | 16.55M | 16.59M | 16.63M |
Total Long-Term Liabilities | 37.74M | 38.91M | 44.59M | 48.97M | 66.43M | 39.32M | 31.59M | 31.38M | 31.26M | 31.54M | 19.47M | 26.05M | 27.65M | 29.53M | 31.14M | 32.99M |
Total Liabilities | 75.69M | 75.76M | 82.39M | 88.64M | 106.24M | 84.05M | 74.46M | 72.81M | 73.87M | 71.7M | 54.22M | 53.37M | 53.65M | 52.04M | 54.73M | 57.77M |
Total Debt | 32.93M | 29.75M | 30.23M | 29.38M | 29.78M | 31.15M | 26.26M | 35.69M | 34.89M | 27.75M | 29.37M | 22.98M | 25.98M | 22.06M | 24.09M | 30.35M |
Common Stock | 42K | 41K | 35K | 34K | 28K | 23K | 16K | 16K | 16K | 13K | 13K | 13K | 13K | 10K | 10K | 10K |
Retained Earnings | -243.14M | -233.53M | -229.59M | -220.53M | -221.82M | -166.33M | -156.58M | -145.96M | -137.99M | -132.55M | -122.64M | -113.24M | -105.09M | -96.03M | -87.71M | -85.33M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -85.33M |
Shareholders Equity | -41.84M | -36.46M | -46.26M | -40.24M | -64.34M | -29.47M | -22.13M | -12.18M | -5.03M | -10.68M | -1.37M | 6.56M | 13.52M | 7.86M | 14.97M | 16.44M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |